Policlinico Sant'orsola-Malpighi
Bologna 40138
4 studies enrolling now · 34 studies all time
What they study most
AML, Acute Myocardial Infarction, Atrial Fibrillation, C3 Glomerulonephritis, C3 Glomerulopathy, C3G, CIED Related Infection, Cardiac Disease, Chronic Lymphocytic Leukemia, Colorectal Cancer Liver Metastases, Complement 3 Glomerulonephritis, Complement 3 Glomerulopathy
Studies at this site
- A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
- A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms — Recruiting now
- A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Recruiting now
- Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients — Recruiting now
- A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) — Recruiting now
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
- A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma — Completed
- Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling
- Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
- Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed
- A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma — Stopped early
- Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
- Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
- Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
- A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma — Completed
- Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
- REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension — Completed
- A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease — Stopped early
- Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
- Extravascular ICD Pivotal Study — Completed
- Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma — Stopped early
- Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML) — Stopped early
- AdaptResponse Clinical Trial — Completed
- Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
- TYRX™ Pocket Health Study — Completed
- DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE — Status unconfirmed
- ECG Belt for CRT Response — Completed
- A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials — Stopped early
- Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
- Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed
- World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
- A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies — Stopped early